MHRA approves Novavax protein-based vaccine for adults over 18
The Medicines and Healthcare products Regulatory Agency has approved the Novavax COVID-19 vaccine for use in adults over 18 years. The decision follows a rigorous review of safety, quality, and effectiveness.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan for full access to every Belfast Herald story and the complete archive.
HealthMHRA approves Novavax protein-based vaccine for adults over 18
Sign in or subscribeBrowse free archive reportsThe Medicines and Healthcare products Regulatory Agency has approved the Novavax COVID-19 vaccine for use in adults over 18 years. The decision follows a rigorous review of safety, quality, and effectiveness.